Stephens Inc. AR Has $746,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Stephens Inc. AR grew its holdings in The Clorox Company (NYSE:CLXFree Report) by 33.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,229 shares of the company’s stock after buying an additional 1,319 shares during the quarter. Stephens Inc. AR’s holdings in Clorox were worth $746,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the business. Fortitude Family Office LLC acquired a new stake in shares of Clorox during the 4th quarter worth about $29,000. Northwest Financial Advisors acquired a new stake in shares of Clorox during the 4th quarter worth about $29,000. First United Bank & Trust acquired a new stake in shares of Clorox during the 4th quarter worth about $31,000. Tyler Stone Wealth Management increased its position in shares of Clorox by 64.5% during the 3rd quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares in the last quarter. Finally, Hartford Financial Management Inc. increased its position in shares of Clorox by 57.1% during the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after purchasing an additional 93 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of a number of recent analyst reports. Evercore ISI dropped their target price on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Citigroup decreased their price objective on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Morgan Stanley reissued an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. Finally, DA Davidson reissued a “neutral” rating and set a $162.00 price objective on shares of Clorox in a report on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $146.43.

Get Our Latest Stock Analysis on CLX

Clorox Stock Down 0.9 %

Shares of NYSE CLX opened at $131.71 on Tuesday. The firm has a market capitalization of $16.36 billion, a PE ratio of 68.24, a price-to-earnings-growth ratio of 2.05 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14. The firm’s 50-day moving average is $139.42 and its 200-day moving average is $144.50.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the firm earned $1.51 EPS. Clorox’s quarterly revenue was down 5.3% compared to the same quarter last year. Equities analysts expect that The Clorox Company will post 5.83 EPS for the current year.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.